Pınar Yıldız GÜLHAN, Özlem ATAOĞLU, Ege GÜLEÇ BALBAY, Nevra Ezgi YAŞLI, Ali Nihat ANNAKKAYA

Sarkoidoz Hastalarında Yeme Tutumunun Değerlendirilmesi

Amaç: Bu çalışmanın amacı sarkoidoz hastalarının yeme tutumlarını araştırmaktır. Gereç ve Yöntem: Çalışmaya 50 sarkoidoz tanılı hasta ve kronik hastalığı olmayan 45 sağlıklı birey dahil edildi. Tüm hastalar National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATP III) kriterlerine göre metabolik sendrom (MetS) açısından değerlendirildi. Tüm katılımcılara Yeme Tutumu Testi (YTT), Beck Depresyon Ölçeği (BDÖ) uygulandı. Testlerin kesme puanları YTT için 30, BDÖ için 17 olarak belirlendi. Hastalar kesme puanlarına göre gruplara ayrıldı. Bulgular: Sarkoidoz olguları ve kontrol grubunun YTT ve BDÖ kesme puanına göre karşılaştırmasında; sarkoidoz hastalarında yeme davranışı bozulma sıklığının arttığını ancak depresyon sıklığının artmadığı görüldü (sırasıyla; p=0,018-p=0,874). Sarkoidoz hastalarında YTT skorlarını anlamlı düzeyde yüksek bulundu; MetS(-); EAT: 15±7, MetS(+); EAT: 27±10 (p

The Evaluation of Eating Attitudes in Patients with Sarcoidosis

Objective: The aim of this present study was to investigate the eating attitudes ofsarcoidosis patients.Methods: 50 patients with sarcoidosis and 45 healthy individuals without chronicdisease were included to study. All participants evaluated for metabolic syndrome(MetS) according to National Cholesterol Education Program's Adult Treatment PanelIII (NCEP-ATP III) criteria. Eating Attitude Test (EAT) and Beck DepressionInventory (BDI) were applied to all participants. All participants evaluated formetabolic syndrome (MetS). The cut-off scores of the tests were 30 for BDI and 17for BDI.Results: When sarcoidosis cases and control group were evaluated according to EATand BDI cut-off scores; it was found that the prevalence of deterioration in eatingbehavior was higher in patients with sarcoidosis than healthy controls but theprevalence of depression was not higher (p=0.018, p=0.874 respectively).We foundthat total EAT scores were significantly higher in sarcoidosis patients who has MetS.MetS(-); EAT: 15±7, MetS(+); EAT: 27±10 p

PDF

___

1. Hunninghake G.W, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 1999;16(2):149–73.
2. Yıldız Gülhan P, Güleç Balbay E, Erçelik M et al. Is sarcoidosis related to metabolic syndrome and insulin resistance? Aging male 2020; 23(1): 53-8. [Epub ahead of print]
3. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999;14(4):735-7.
4. Sucaklı MH, Çelik M. The Etiology and Epidemiology of Obesit. Türkiye Klinikleri J Fam Med-Special Topics 2015;6(3):1-6.
5. Cozier YC, Coogan PF, Govender P et al. Obesity and weight gain in relation to incidence of sarcoidosis in US blackwomen:data from the Black Women’s Health Study. Chest 2015;147(4):1086–93.
6. Ulaş B, Uncu F, Üner S. Prevalence and Affecting Factors of Potential Eating Disorders Among Students of Health Higher Education. İnönü Üniversitesi Sağlık Bilimleri Dergisi 2013;2(2):15-22.
7. Kaya A, Yılmaz A, Demirhan Bİ. The Evaluation of Relationship Between Eating Attitudes and Body Mass Index in Obese Patient. Euras J Fam Med 2016;5(3):117-9.
8. Garner DM, Garfinkel PE. The Eating Attitudes Test:An index of the symptoms of anorexia nervosa. Psychol Med 1979;9(2):273-79.
9. Savaşır I, Erol N. Yeme Tutum Testi:Anoreksi Nervoza Belirtileri İndeksi. Psikoloji Dergisi 1989;7(23):19- 25.
10. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry 1961;4(6):561-71.
11. Hisli N. Beck Depresyon Envanterinin üniversite öğrencileri için geçerliliği ve güvenirliliği. Psikoloji Dergisi 1989;7(23):3-13.
12. Harpsoe MC, Basit S, Andersson M, et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol 2014;43(3):843–55.
13. Fantuzzi G. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 2005;115(5):911–20.
14. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry 1992;149(2):227-34.
15. Scott KM, McGee MA, Wells JE et al. Obesity and mental disorders in the adult general population. J Psychosom Res 2008;64(1):97-105.
16. Cozier CY, Praveen G, Jeffry SB. Obesity and sarcoidosis: consequence or contributor? Current Opinion in Pulmonary Medicine 2018;24(5):487-94.
17. Vaag A, Brons C, Apel JS et al. Metabolic consequences of overeating. Ugeskr Laeger 2006;168(2):183–7.
18. Hudson JI, Lalonde JK, Coit CE, et al. Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr. 2010;91(6):1568–73.
19. Herpetz S, Albus C, Wagener R, et al. Comorbidity of diabetes and eating disorders. Does diabetes control reflect disturbed eating behavior? Diabetes Care1998;21(7):1110-6.
20. Gülfizar Sözeri Varma. Neuroinflammatory Hypothesis in Major Depressive Disorder. Current Approaches in Psychiatry 2014;6(1):1-9
21. Duivis HE, Vogelzangs N, Kupper N et al. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 2013; 38(9):1573-85.
22. Gerke AK, Judson MA, Cozier YC et al. Disease Burden and Variability in Sarcoidosis. Ann Am Thorac Soc. 2017; 14(6):421–28.
23. Willemien P. E. de Kleijn, Marjolein Drent, Jolanda De Vries. Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis. British Journal of Health Psychology 2013:18(2):439–52.

ISSN: 1309-3878
Yayın Aralığı: Yılda 3 Sayı
Başlangıç: 2009
Yayıncı: Düzce Üniversitesi Tıp Fakültesi Aile Hekimliği AD adına Yrd.Doç.Dr.Cemil Işık Sönmez